Author

Eun-Ho Cho

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Hoyun KwakiD· 2 shared Jae Young SeongiD· 2 shared Jong‐Ik HwangiD· 2 shared Minhyeok LeeiD· 2 shared Nui HaiD· 2 shared Sangjin YooiD· 2 shared Soon-Gu KwoniD· 2 shared Anu Shahapal· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Hoyun KwakORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Is FAM19A5 an adipokine? Peripheral FAM19A5 in wild-type, FAM19A5 knock-out, and LacZ knock-in mice.

Hoyun Kwak, Eun-Ho Cho, Eun Bee Cho, Yoo-Na Lee, Anu Shahapal, Hyo Jeong Yong, Arfaxad Reyes‐Alcaraz, Yongwoo Jeong, Yerim Lee, Minhyeok Lee, Nui Ha, Sitaek Oh, Jae Keun Lee, Won Suk Lee, Won Kyum Kim, , Jae Young Seong

This study examines FAM19A5 expression and function in mice, finding low peripheral levels and no significant interaction with S1PR2.

Molecules and Cells · Oct 18, 2024Peer-reviewedGenetics

Antibody-based immunotherapy targeting FAM19A5 reverses synaptic loss and improves cognitive function in Alzheimer's disease.

Hanbyul Kim, Sangjin Yoo, Hoyun Kwak, Shi‐Xun Ma, Ryunhee Kim, Minhyeok Lee, Nui Ha, Soonil Pyo, Soon-Gu Kwon, Eun-Ho Cho, Sang‐Myeong Lee, Juwon Jang, Won‐Kyum Kim, Hae‐Chul Park, Minkyung Baek, , Jae Young Seong

This paper shows that targeting FAM19A5 with a monoclonal antibody improves synaptic function and cognition in Alzheimer's disease models.

bioRxiv · Nov 22, 2023 · PreprintNeuroscience